Pre-Op Liraglutide Cuts Post-Op Plasma Glucose in T2DM

This article originally appeared here.
Share this content:
Pre-Op Liraglutide Cuts Post-Op Plasma Glucose in T2DM
Pre-Op Liraglutide Cuts Post-Op Plasma Glucose in T2DM

TUESDAY, Dec. 19, 2017 (HealthDay News) -- For patients with type 2 diabetes mellitus undergoing non-cardiac surgery, premedication with liraglutide is associated with reduced median plasma glucose one hour postoperatively, according to a study published online Dec. 12 in Anaesthesia.

J.A.W. Polderman, from Academic Medical Centre Amsterdam, and colleagues randomized patients aged 18 to 75 years with type 2 diabetes mellitus undergoing non-cardiac surgery to receive premedication with liraglutide (44 patients), glucose-insulin-potassium infusion (53 patients), or insulin bolus regimen (53 patients); the glucose target was <8 mmol/L-1.

The researchers found that the liraglutide group had lower median plasma glucose one hour postoperatively compared with the insulin infusion and insulin bolus groups (6.6 versus 7.5 and 7.6 mmol/L-1, respectively). There was no difference between the groups in the incidence of hypoglycemia and postoperative complications. Preoperative nausea occurred in six patients in the liraglutide group compared with no patients in the insulin infusion and insulin bolus groups.

"The preoperative administration of liraglutide stabilized perioperative plasma glucose levels and reduced perioperative insulin requirements, at the expense of increased preoperative nausea rates," the authors write.

Two authors disclosed financial ties to Novo Nordisk, the manufacturer of liraglutide.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Global Prevalence of Insufficient Activity 27.5 Percent

Global Prevalence of Insufficient Activity 27.5 Percent

Levels of insufficient physical activity stable between 2001, 2016; increase seen in high-income countries

HTN Tx Intensification Common Upon Discharge in U.S. Vets

HTN Tx Intensification Common Upon Discharge in U.S. ...

Fourteen percent of older adults admitted to hospital for non-cardiac conditions had intensification of tx

Quarterly Canakinumab Reduces Risk for Gout Attacks

Quarterly Canakinumab Reduces Risk for Gout Attacks

Doesn't affect serum uric acid levels over time, but targets interleukin-1β

is free, fast, and customized just for you!




Already a member?

Sign In Now »